Cargando…
Visual Parameters and Retinal Morphology for Polypoidal Choroidal Vasculopathy Pre- and Post-Intravitreal Ranibizumab with or without Photodynamic Therapy: A Short-Term Prospective Study
The objective of this study was to compare visual parameters and retinal layers’ morphology pre-treatment (baseline) and 6 months post-treatment in polypoidal choroidal vasculopathy (PCV) eyes. A single centre, longitudinal, prospective study was conducted at a public tertiary hospital of Malaysia....
Autores principales: | Ghoshal, Rituparna, Sharanjeet-Kaur, Sharanjeet, Fadzil, Norliza Mohamad, Ghosh, Somnath, Ngah, Nor Fariza, Aziz, Roslin Azni Binti Abd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967335/ https://www.ncbi.nlm.nih.gov/pubmed/33806713 http://dx.doi.org/10.3390/ijerph18052581 |
Ejemplares similares
-
Patient-Perceived Benefit of Treatment in Polypoidal Choroidal Vasculopathy: A Pilot Study
por: Ghoshal, Rituparna, et al.
Publicado: (2020) -
Baseline Optical Coherence Tomography Parameters That May Influence 6 Months Treatment Outcome of Polypoidal Choroidal Vasculopathy Eyes with Combination Therapy: A Short-Term Pilot Study
por: Ghoshal, Rituparna, et al.
Publicado: (2021) -
Correlation between Visual Functions and Retinal Morphology in Eyes with Early and Intermediate Age-Related Macular Degeneration
por: Ghoshal, Rituparna, et al.
Publicado: (2020) -
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
por: Sonoda, Shozo, et al.
Publicado: (2013) -
Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial
por: Lim, Tock H., et al.
Publicado: (2020)